[Federal Register Volume 65, Number 156 (Friday, August 11, 2000)]
[Notices]
[Page 49248]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-20371]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director; Notice of Meeting

    Pursuant to Pub. L. 92-463, notice is hereby given of a meeting of 
the Advisory Committee to the Director, NIH.
    The entire meeting will be open to the public as indicated below, 
with attendance limited to space available. Individuals who plan to 
attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should inform the 
Contact Person listed below in advance of the meeting. The meeting will 
take place via conference call with the members. A speaker phone will 
be installed in the conference room for the public to listen to the 
discussion.

    Name of Committee: Advisory Committee to the Director, NIH.
    Date: September 14, 2000.
    Time: 4-5 p.m.
    Agenda: To discuss and provide advice on the final Report from 
the Working Group on NIH Oversight of Clinical Gene Transfer 
Research.
    Place: National Institutes of Health, 1 Center Drive, Building 
1, Room 151, Bethesda, Maryland 20892.
    Contact: Ms. Janice C. Ramsden, Special Assistant to the 
Principal Deputy Director, NIH, National Institutes of Health, 
Building 1, Room 235, Bethesda, Maryland 20892, [email protected], 
Telephone: (301) 496-0959.

    Dated: August 4, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-20371 Filed 8-10-00; 8:45 am]
BILLING CODE 4140-01-M